Kymera Therapeutics, Inc. (KYMR) Financials
KYMR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.6 billion | 139.9 million |
| March 31, 2026 | 1.7 billion | 129.4 million |
| Dec. 31, 2025 | 1.7 billion | 163.1 million |
| Sept. 30, 2025 | 1.1 billion | 155.8 million |
KYMR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -54.5 million | 18.9 million |
| March 31, 2026 | -89.3 million | 16.0 million |
| Dec. 31, 2025 | -66.9 million | 14.5 million |
| Sept. 30, 2025 | -27.3 million | 15.8 million |
KYMR Net Income
No data available :(
KYMR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 691.0 million | - | 82.2 million |
| March 31, 2026 | 650.9 million | - | 80.5 million |
| Dec. 31, 2025 | 848.3 million | - | 68.5 million |
| Sept. 30, 2025 | 505.7 million | - | 70.3 million |
KYMR Shares Outstanding
KYMR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 473000 | 119.5 million | 21.1 million | - |
| March 31, 2026 | 434000 | 98.2 million | 20.4 million | - |
| Dec. 31, 2025 | 106000 | 83.9 million | 16.9 million | - |
| Sept. 30, 2025 | 181000 | 74.1 million | 17.3 million | - |
KYMR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 65.0 million | - |
| March 31, 2026 | 34.4 million | 2.0 million |
| Dec. 31, 2025 | 2.9 million | -76.2 million |
| Sept. 30, 2025 | 2.8 million | 74.1 million |
KYMR
Price: $108.14
52 week price:
Earnings Per Share: -3.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 492600
Market Capitalization: 8.8 billion